Standout Papers

Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-... 2016 2026 2019 2022 319
  1. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft (2016)
    Muhammad M. Mohiuddin, Avneesh K. Singh et al. Nature Communications

Immediate Impact

1 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Why do patients with cancer die?
2024 Standout
3 intermediate papers

Works of Philip C. Corcoran being referenced

Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft
2016 Standout
Impact of Revised Stage Classification of Lung Cancer on Survival
1999
and 1 more

Author Peers

Author Last Decade Papers Cites
Philip C. Corcoran 886 433 60 191 32 1.2k
Elizabeth Montgomery 333 220 236 254 40 1.5k
Lachy McLean 400 156 84 196 23 1.7k
Bryan R. Hewlett 531 119 89 202 21 1.5k
N. Schnoy 666 89 78 265 46 1.4k
Alina C. Iuga 314 125 43 451 38 1.4k
Nicolas Delaleu 254 194 58 313 32 1.4k
M. F. Flessner 364 260 67 369 25 1.4k
Anand P. Chaudhry 408 149 317 419 47 1.5k
Paul E. Michelśon 284 162 107 103 31 1.4k
Lucio Pallarés 330 210 218 65 17 1.2k

All Works

Loading papers...

Rankless by CCL
2026